Document text
Principal Investigator: Karran Phillips
Organization: NATIONAL INSTITUTE ON DRUG ABUSE
Fiscal Year: 2020
Award: $1,253,916
Funding agency: National Institute on Drug Abuse
The Office of the Clinical Director (OCD), Intramural Research Program (IRP), National Institute on Drug Abuse (NIDA), NIH provides clinical research support to three clinical research branches, the Clinical Pharmacology and Therapeutics Research Branch (CPTRB), the Translational Addiction Medicine Brnch (TAMB), and the Neuroimaging Research Branch (NRB). The scope of the research program is broad and is strongly represented in the behavioral and pharmacological treatments for opioid use disorder and other substance use disorders as well as non-invasive brain stimulation and neuroimaging.
The Office of the Clinical Director staff includes an Administrative Professional who provides primary support to the Clinical Director and Deputy Clinical Director. The Administrative Professional also coordinates with the IRP Pharmacy, Matthews Media Group, Inc. (MMG), Medical Records Department, the Mid-Level Providers and Nursing. In April 2019 the OCD added a Staff Clinician in order to meet the growing clinical needs resulting from the addition of a new tenure track clinical investigator in Jan 2019 and a tenured clinical investigator in July 2019. The 2 full time Mid-Level Providers (Federal) medically screen potential participants as well as assist in the day to day running of various protocols. Three full time nurses also staff and run protocols and ensure patient safety and quality clinical care. Additional clinical staff supporting the NIDA/IRP clinical program includes 6 full time Research Associates. These positions are part of the clinical services provided through the Kelly Services Contract with NIDA/IRP. The OCD staff includes one counselor and one clinic manager who coordinate the Archway Outpatient Addiction Treatment Clinic. Of the 3 contract nurses, one nurse retired in FY2019 and was replaced with a contract nurse, a second contract nurse was added in May 2020. Through a contract with JHBMC (Johns Hopkins Bayview Medical Campus) managed by the OCD, our 7 clinical PIs have access to an extensive clinical infrastructure and array of services including professional physician consultations, laboratory medicine, radiology, and emergency services. The Addictions IRB was consolidated into the NIH IRB in Nov 2019. Two IRB staff were transitioned to support the OCD's Translational Research Initiative (TRI). In FY2019 a Protocol Navigator supported by the Office of Research Support and Compliance (ORSC) was added to coordinate with the consolidated NIH IRB. The OCD also supports the Data Safety and Monitoring Board (DSMB) which is comprised of 2 statisticians, a secretary, and 4-6 outside experts in pharmacology, clinical research, neurobiology, and psychiatry. The DSMB meets quarterly to review protocols and ensure patient safety and compliance with protocol monitoring and safety procedures.
The OCD oversees a contract with MMG which provides advertising, recruiting and, research participant screening for all NIDA IRP protocols in the Baltimore Washington area. At this time MMG employs 6 screening specialists, 2 participant counselors, 1 medical assistant and an on-site manager.
The Medical Records Department at NIDA/IRP is designed to maintain department compliance of Policy and Procedures while safekeeping the Privacy of over 6600 electronic (HuRIS System) medical records annually. Hardcopy documents of the medical records currently include signed consents and outside medical records; otherwise everything is electronic. Some older charts are available on microfilm. We continue to broaden our use of electronic consent and quiz procedures in our studies which further enhances our digital profile. This is done according to the National Institute of Health, Federal and State Rules and Regulations (Including the Privacy Act of 1974 and HIPPA).
The NIDA IRP Pharmacy employs two full time pharmacists and one pharmacy technician. The NIDA IRP pharmacy currently supports about 20 clinical studies including opioid and other drug addiction treatment studies and 40 researchers/labs for nonclinical studies. One pharmacist devotes about 80% of her time supporting the clinical studies and 20% nonclinical studies. The other pharmacist spends about 50% effort on clinical and 50% effort on nonclinical studies. Clinical research support includes reviewing, preparing, compounding, and dispensing the study medications. Nonclinical support includes ordering, compounding, dispensing, and laboratory auditing. In addition, the pharmacy monitors drug inventories, and meets all DEA and FDA regulatory requirements including licensing and IND reporting.
Since July 2020 the OCD has designed and implemented a staff asymptomatic SARS CoV2 testing system that includes registration/scheduling, specimen collection, delivery of samples to NIH Division of Laboratory Medicine, result reporting, and contact tracing for both NIDA and the NIA with whom we share a building. In September 2020 the OCD will begin to support a participant asymptomatic SARS CoV2 testing program. Additionally the OCD provides Basic Life Saving (BLS) training and certification, as well as naloxone overdose prevention training for the entire NIDA IRP including administrative, basic science, and clinical staff.
Terms: <2019 novel coronavirus><2019-nCoV><Advertising><Area><Baltimore><Basic Research><Basic Science><Behavior Conditioning Therapy><Behavior Modification><Behavior Therapy><Behavior Treatment><Behavioral Conditioning Therapy><Behavioral Modification><Behavioral Therapy><Behavioral Treatment><Brain><Brain Nervous System><Certification><Chemical Dependence><Clinic><Clinical><Clinical Investigator><Clinical Pharmacology><Clinical Protocols><Clinical Research><Clinical Services><Clinical Study><Clinical Trials Data Monitoring Committees><Communicable Disease Contact Tracing><Conditioning Therapy><Consent><Consultations><Contact Tracing><Contract Services><Contracting Opportunities><Contracts><Counselor><Data Monitoring Committees><Data and Safety Monitoring Boards><Discipline of Nursing><Drug Addiction><Drug Dependence><Drug Dependency><Drug Kinetics><Drug Monitoring><Drugs><Emergency medical service><Encephalon><Ensure><Equipment and supply inventories><General Radiology><Human Subject Research><IRB><IRBs><Infectious Disease Contact Tracing><Infrastructure><Inpatients><Institutional Review Boards><Intramural Program><Intramural Research Program><Inventory><Investigators><Laboratories><Licensing><Life><Medical><Medical Records><Medical center><Medication><Medicine><Microfilm><Monitor><Movement><NIDA><NIH><Naloxone><National Institute of Drug Abuse><National Institute on Drug Abuse><National Institutes of Health><Neurobiology><Nurses><Nursing><Nursing Field><Nursing Profession><Opiates><Opioid><Out-patients><Outpatients><Participant><Patient Compliance><Patient Recruitments><Pharmaceutic Preparations><Pharmaceutical Preparations><Pharmacies><Pharmacists><Pharmacokinetics><Pharmacological Treatment><Pharmacology><Pharmacy facility><Physicians><Policy Compliance><Position><Positioning Attribute><Postdoc><Postdoctoral Fellow><Privacy><Privacy Act><Procedures><Process><Professional counselor><Protocol><Protocols documentation><Provider><Psychiatry><R-Series Research Projects><R01 Mechanism><R01 Program><Radiology><Radiology Specialty><Regulation><Reporting><Research><Research Assistant><Research Associate><Research Grants><Research Personnel><Research Project Grants><Research Projects><Research Support><Researchers><Running><SARS-CoV-2><SARS-CoV2><SARS-associated coronavirus 2><SARS-coronavirus-2><SARS-related coronavirus 2><Safety><Safety Monitoring Boards><Sampling><Savings><Schedule><Services><Severe acute respiratory syndrome coronavirus 2><Site><Specialist><Substance Use Disorder><System><Testing><Therapeutic Human Experimentation><Therapeutic Research><Time><Training><Translational Research><Translational Science><United States National Institutes of Health><Washington><Wuhan coronavirus><addiction><addictive disorder><behavior intervention><behavioral intervention><body movement><clinical care><clinical infrastructure><compliance behavior><design><designing><digital><drug/agent><emergency service><microfiche><neuro-imaging><neurobiological><neuroimaging><nurse><opiate use disorder><opioid use disorder><overdose prevention><participant recruitment><patient adherence><patient cooperation><patient safety><post-doc><post-doctoral><procedure safety><programs><protocol development><recruit><research study><safe procedure><sample collection><screening><specimen collection><tenure process><tenure track><therapy compliance><therapy cooperation><translation research><treatment compliance>